Residual Risk of HBV in African Blood Banks: Systematic Review and Meta-Analysis
International STD Research & Reviews,
Background: Blood transfusions carry the risk of transmitting blood-borne infections. A precise estimate of the transfusion risk of viral infection will help to determine the effect of new and current safety measures in sub-Saharan Africa. This study proposes to estimate the residual risk of HBV in blood banks in African countries and to compare them to other countries in the South.
Methods: The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. PubMed, Medline, Google Scholar and Zotero were accessed. The eligibility criteria were based on published studies that had blood donors as participants, looking at the residual risk of HBV in developing countries and the technique was based on the search for HBsAg or Hepatitis B Core Antibodies or Nucleic Acid (DNA) testing. The Cochrane tool was used to assess the risk of bias.
Results: Twelve articles comprising 71,207 allogeneic and hepatitis B surface antigen (HBsAg)-negative blood donations were included in the meta-analysis. A total of 4912 HBsAg negative African donation including (51.0%) new donors and (49.0%) from regular donors. 80.8% of them were male and the median age was 28 years. Of 1225 HBV strains (47% and 53.4% incident cases) were frequencies in sub-Saharan Africa and in other Southern countries respectively. Considering the twelve participating blood centres as a whole, the incidence rate of new infections was high (4905.1) in sub-Saharan Africa than (869.7) in other Southern countries per 100,000 person-years. In contrast, the estimated residual risk in sub-Saharan Africa (5913 in 1 million donations) was five times higher than estimated in other Southern countries (1048.4 in 1 million donations).
Conclusion: Blood donations with HBsAg undetectable by routine testing and low levels of HBV DNA are extremely common in sub-Saharan Africa, at a rate of 5913 per 1 million donations. Given that at least several of these samples could reflect contamination or a false negative result, elimination of infection by a test limited to HBsAg does not prevent transmission.
- Blood transfusion
- Residual risk
- sub Saharan Africa
- D. Maulot-Bangola
How to Cite
DOI : 10.4084/mjhid.2018.041
Ware AD, Jacquot C, Tobian AAR, Gehrie EA, Ness PM, Bloch EM. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sanguinis. 2017;113:3–12.
Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, et al. Occult hepatitis B virus infection in nigerian blood donors and hepatitis B virus transmission risks. Roques P, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2015;10(7):e0131912.
Nambei WS, Rawago-Mandjiza D, Gbangbangai E. Seroepidemiology of HIV, syphilis and hepatitis B and C viruses among blood donors in Bangui, Central African Republic. Médecine et Santé Tropicales [Internet]. John Libbey Eurotext. 2016;26(2):192–8.
Busch MP, Bloch EM, Kleinman S. Prevention of transfusion-transmitted infections. Blood [Internet]. American Society of Hematology. 2019; 133(17):1854–64.
Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfusion Clinique et Biologique [Internet]. Elsevier BV. 2017 ;24(3):189–95.
O’Brien SF, Yi QL, Fan W, Scalia V, Goldman M, Fearon MA. Residual risk of HIV, HCV and HBV in Canada. Transfusion and Apheresis Science [Internet]. Elsevier BV. 2017;56(3):389–91.
Rosenthal P. Faculty opinions recommendation of detection of hepatitis B virus infection in German blood donors 2008-2015. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature [Internet]. Faculty Opinions Ltd; 2020.
Dodd RY, Crowder LA, Haynes JM, Notari EP, Stramer SL, Steele WR. Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016. Transfusion Medicine Reviews [Internet]. Elsevier BV. 2020;34(2):81–93.
Rajput MK. Automated Triplex (HBV, HCV and HIV) NAT assay systems for blood screening in India. Journal of Clinical and Diagnostic Research [Internet]. JCDR Research and Publications ; 2016.
Corrêa AS de M, Lamarão LM, Vieira PCM, de Castro RBH, de Almeida NCC, de Castro JAA, et al. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil. Khudyakov YE, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2018;13(12): e0208414.
Ye X, Li T, Shao W, Zeng J, Hong W, Lu L, et al. Nearly half of ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China. BMC Infectious Diseases [Internet]. Springer Science and Business Media LLC. 2019;19(1).
Roberts DJ, Field S, Delaney M, Bates I. Problems and approaches for blood transfusion in the developing countries. Hematology/Oncology Clinics of North America [Internet]. Elsevier BV; 2016;30(2):477–95.
Candotti D, Tagny-Tayou C, Laperche S. Challenges in transfusion-transmitted infection screening in Sub-Saharan Africa. Transfusion Clinique et Biologique [Internet]. Elsevier BV; 2021;28(2):163–70.
Lelie N, Bruhn R, Busch M, Vermeulen M, Tsoi W, Kleinman S, et al. Detection of different categories of hepatitis B virus (HBV) infection in a multi‐regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV‐DNA testing. Transfusion [Internet]. Wiley; 2016 ;57(1):24–35.
Page MJ, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, mulrow cindy d, et al. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. Center for Open Science ; 2020.
Albuquerque I de C, Sousa MT, Santos MDC, Nunes JDC, Moraes MJD, Gomes-Gouvêa MS, Pinho JRR, Carrilho FJ, Fonseca LMB, Ferreira A de SP, et al. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil. Journal of Medical Virology. 2017;89(3): 458 462.
Hou W, Huo Z, Du Y, Wang C, Syn WK, et al. Characteristics of amino acid substitutions within the “a” determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs. Clinics and Research in Hepatology and Gastroenterology. 2020;44(6) :923 931.
Pondé RAA. Acute hepatitis B virus infection or acute exacerbation of chronic hepatitis B infection : The differential serological diagnosis. European Journal of Clinical Microbiology & Infectious Diseases. 2016;35(1) :29 40.
Malve B, Eschlimann M, Galgey S, Fenaux H, Zoulim F, Goehringer F, Rabaud C, May T, Jeulin H, Schvoerer E, et al. Impact of deletions and mutations in hepatitis B virus envelope proteins on serological profile and clinical evolution. Virus Research. 2017;238:141 147.
Adetunji SO, Donbraye E, Alawode-Obabiyi L, Akinniyi O, et al. Serological profile of HBV infection among apparently healthy hospital attendees. Journal of Immunoassay and Immunochemistry. 2019;40(3):237 249.
Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nature Reviews Gastroenterology & Hepatology [Internet]. Springer Science and Business Media LLC. 2016;13(11):643–53.
Chulanov V, Pshenichnaya N, Leblebicioglu H. Genetic diversity of the hepatitis B virus and its epidemiological significance. Viral Hepatitis: Chronic Hepatitis B [Internet]. Springer International Publishing. 2018;41–50.
Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. The evolution and clinical impact of hepatitis B virus genome diversity. Nature Reviews Gastroenterology & Hepatology [Internet]. Springer Science and Business Media LLC. 2020;17(10):618–34.
Candotti D, Laperche S. Hepatitis B virus blood screening: need for reappraisal of blood safety measures? Frontiers in Medicine [Internet]. Frontiers Media SA. 2018;5.
Wongjarupong N, Oli S, Sanou M, Djigma F, Kiba Koumare A, Yonli AT, et al. Distribution and Incidence of blood-borne infection among blood donors from regional transfusion centers in burkina faso: A comprehensive study. The American Journal of Tropical Medicine and Hygiene [Internet]. American Society of Tropical Medicine and Hygiene. 2021;104(4):1577–81.
Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL. Blood donor testing for hepatitis B virus in the United States: Is there a case for continuation of hepatitis B surface antigen detection? Transfusion [Internet]. Wiley. 2018;58(9):2166–70.
Attia A, Elmetwalli A. Screening of occult hepatitis B virus infection among egyptian blood donors. Medical Journal of Viral Hepatitis [Internet]. Egypts Presidential Specialized Council for Education and Scientific Research. 2021;5.2(2):27–31.
El‐Nabi SH, El‐Garawani I, Ismail F, Abdelsameea E. Anti‐HBc and hepatitis B virus DNA among HBsAg‐negative blood donors from the main central blood bank units in Eastern Libya. Transfusion Medicine [Internet]. Wiley. 2020;30(5):401–5.
Grubyte S, Urboniene J, Nedzinskiene L, Jelinskaite A, Zagminas K, Ambrozaitis A, et al. Prevalence, incidence and residual risk of transfusion transmitted viruses (HBV, HCV and HIV infections) in Lithuanian blood donors from 2004 to 2018: The incidence/window-period model study. Chemin I, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2021;16(2):e0246704.
Seri B, Minga A, Gabillard D, Dembele B, Konate S, Le Carrou J, et al. Twenty-year evolution of hepatitis B virus and human immunodeficiency virus prevalence and incidence in voluntary blood donors in Côte d’Ivoire. Open Forum Infectious Diseases [Internet]. Oxford University Press (OUP). 2018;5(4).
Seed CR. Screening and confirmatory testing strategies for the major transfusion-transmissible viral infections. ISBT Science Series [Internet]. Wiley. 2014;9(1):6–13.
Aluora PO, Muturi MW, Gachara G. Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya. Virology Journal [Internet]. Springer Science and Business Media LLC. 2020;17(1).
Osei E, Lokpo SY, Agboli E. Sero-prevalence of hepatitis B infection among blood donors in a secondary care hospital, Ghana (2014): A retrospective analysis. BMC Research Notes [Internet]. Springer Science and Business Media LLC. 2017;10(1).
Yambasu EE, Reid A, Owiti P, Manzi M, Sia Murray MJ, Edwin AK. Hidden dangers-prevalence of blood borne pathogens, hepatitis B, C, HIV and syphilis, among blood donors in Sierra Leone in 2016: opportunities for improvement: a retrospective, cross-sectional study. Pan African Medical Journal [Internet]. Pan African Medical Journal. 2018;30.
Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health [Internet]. Springer Science and Business Media LLC. 2018;18(1).
Kabemba BH, Kasendue EP, Shiku MA, Mukena TS, Kasolva TC, Kabingie NG, et al. Seroprevalence of hepatitis B virus infection (HBsAg) in rural blood donors, moba, tanganyika province, Democratic Republic of Congo (2014 to 2016). OALib [Internet]. Scientific Research Publishing, Inc. 2017;04(03):1–5.
Mohammed S, Essel HB, et al. Motivational factors for blood donation, potential barriers, and knowledge about blood donation in first-time and repeat blood donors. BMC Hematology, 2018; 18(1):36.
Asamoah-Akuoko L, Hassall OW, Bates I, Ullum H, et al. Blood donors’ perceptions, motivators and deterrents in Sub-Saharan Africa – a scoping review of evidence. British Journal of Haematology. 2017;177(6) :864 877.
Teklemariam Z, Mitiku H, Weldegebreal F, et al. Seroprevalence and trends of transfusion transmitted infections at Harar blood bank in Harari regional state, Eastern Ethiopia : Eight years retrospective study. BMC Hematology. 2018;18(1):24.
Kasraian L, Hosseini S, Dehbidi S, Ashkani-Esfahani S, et al. Return rate in blood donors : A 7-year follow up. Transfusion Medicine. 2020; 30(2):141 147.
Mremi A, Yahaya JJ, Nyindo M, Mollel E, et al. Transfusion-transmitted infections and associated risk factors at the Northern zone blood transfusion center in Tanzania : A study of blood donors between 2017 and 2019. PLOS ONE. 2021;16(3):e0249061.
Abstract View: 109 times
PDF Download: 47 times